These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11277095)

  • 1. Impressive amelioration of clinical (NYHA class) and echocardiographic parameters in heart failure patients treated with amiodarone and carvedilol.
    Conraads V; Brutsaert D; Vrints C
    Eur J Heart Fail; 2001 Jan; 3(1):145-6. PubMed ID: 11277095
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
    Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade and amiodarone therapy: twin brothers from different parents.
    Eichhorn EJ; Hamdan MH
    J Card Fail; 1998 Dec; 4(4):289-94. PubMed ID: 9924850
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
    Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
    Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
    Tsetskhladze E; Khintibidze I
    Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.
    Krum H; Shusterman N; MacMahon S; Sharpe N
    J Card Fail; 1998 Dec; 4(4):281-8. PubMed ID: 9924849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol.
    Fukumoto K; Kobayashi T; Komamura K; Kamakura S; Kitakaze M; Ueno K
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):423-7. PubMed ID: 16415527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of carvedilol in atrial fibrillation: insights from clinical trials.
    Gheorghiade M; Lukas MA
    Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of amiodarone in patients with heart failure.
    Torp-Pedersen C; Metra M; Spark P; Lukas MA; Moullet C; Scherhag A; Komajda M; Cleland JG; Remme W; Di Lenarda A; Swedberg K; Poole-Wilson PA;
    J Card Fail; 2007 Jun; 13(5):340-5. PubMed ID: 17602979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
    Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
    Lou YF; Shi XP; Tong H; Yu GY; Yao GD; Dong K
    Circ J; 2009 Dec; 73(12):2363; author reply 2364. PubMed ID: 19940373
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
    Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
    Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
    [No Abstract]   [Full Text] [Related]  

  • 14. Carvedilol for heart failure, with care.
    Cleland JG; Swedberg K
    Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
    [No Abstract]   [Full Text] [Related]  

  • 15. Carvedilol in class IV heart failure.
    Hoffman I
    J Am Coll Cardiol; 1999 Dec; 34(7):2149-50. PubMed ID: 10588239
    [No Abstract]   [Full Text] [Related]  

  • 16. Carvedilol therapy in heart failure--III.
    Lee YC
    J Am Coll Cardiol; 1995 Nov; 26(5):1400-1. PubMed ID: 7594061
    [No Abstract]   [Full Text] [Related]  

  • 17. Carvedilol: a countermeasure to heart failure.
    Barkman A; Pooler C
    Dimens Crit Care Nurs; 2001; 20(5):11-6. PubMed ID: 22076514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
    Krum H; Ninio D; MacDonald P
    Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique effects of carvedilol on noradrenaline release in the human heart.
    Richardt G; Richardt D; Adler S; Kraatz E; Nötzold A; Kurz T
    Eur J Heart Fail; 2002 Mar; 4(2):147-9. PubMed ID: 11959042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.